MarketBeat estimates November 12 results for Marchex stock

Published on 10/20/2026 at 18:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Marchex posted USD 11.00 million in Q2 revenue on June 30, 2026. Marchex stock costs EUR 1.16 on October 20, 2026 at 6:31 p.m. CEST.

Analyst date and price

MarketBeat estimates that Marchex will report third-quarter results on November 12, 2026.
Second-quarter revenue was USD 11.00 million for the period ended June 30, 2026.
Marchex stock costs EUR 1.16 at Lang & Schwarz on October 20, 2026 at 6:31 p.m. CEST.

MCHX, US56624R1086, Illustration mit AI erstellt.

Marchex (ISIN US56624R1086) is estimated to report third-quarter results on November 12, 2026, according to MarketBeat. The date comes after second-quarter revenue of USD 11.00 million and a net loss of USD 0.41 million for the period ended June 30, 2026. At Lang & Schwarz, Marchex stock was trading at EUR 1.16 on October 20, 2026 at 6:31 p.m. CEST.

Q2 revenue sets the baseline

Remio reported that second-quarter revenue fell from USD 11.70 million a year earlier to USD 11.00 million, while Marchex posted a USD 0.40 million net loss. Adjusted EBITDA reached USD 0.70 million, or USD 1.70 million excluding USD 1.00 million in reorganization and acquisition-related costs.

The same report described combined third-quarter revenue guidance of USD 16.00 million to USD 16.50 million and adjusted EBITDA guidance of USD 2.30 million to USD 2.50 million before specified costs. That range is the clearest operating benchmark for the November report.

Price position and valuation

On Nasdaq, MCHX was last at USD 1.28 on October 20, 2026 at 12:21 p.m. ET. MarketBeat listed a 52-week range of USD 1.15 to USD 2.00 on October 16, 2026, placing the US quote USD 0.72 below the reported high.

Marchex had a market capitalization of USD 56.8 million and a price-to-earnings ratio of minus 10.88 on October 20, 2026. The negative ratio reflects the companys loss-making position rather than a conventional earnings valuation.

What will November 12 test?

MarketBeat estimates third-quarter revenue of USD 16.24 million and earnings per share of USD 0.04. Those figures stand against the second-quarter revenue base of USD 11.00 million and the reported loss of USD 0.01 per share.

The Archenia acquisition is central to the operating comparison. Marchex added outcome-based customer acquisition capabilities, while its existing business centers on conversation intelligence and analytics, according to the companys investor-relations overview at Marchex. Investors can therefore compare reported revenue with the combined guidance and examine whether adjusted EBITDA improves without the same level of integration costs.

Comparison with peers

Marchex: P/E minus 10.88, market capitalization USD 56.8 million.

Omnicom Group (NYSE, USD): up 1.83 percent, P/E 43.75, market capitalization USD 22.2 billion.

TTEC Holdings (Nasdaq, USD): down 7.10 percent, P/E minus 0.35, market capitalization USD 74.2 million.

Stock price and reporting date

Marchex combines a USD 56.8 million market capitalization with an estimated November 12 earnings date and a third-quarter revenue estimate of USD 16.24 million. The next report will provide the first direct test of the combined business against the guidance range.

The further course of trading is shown by the continuously updated real-time quote of Marchex stock.